← Browse by Condition
Medical Condition

anemia

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 3, EARLY_Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for anemia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — anemia Clinical Trials

How many clinical trials are currently recruiting for anemia?
ClinicalMetric currently tracks 15 actively recruiting clinical trials for anemia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 15. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for anemia?
anemia research spans Phase 1 (2 trials), Phase 2 (2 trials), Phase 3 (2 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a anemia clinical trial?
Eligibility criteria for anemia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
2
Phase 3
2
Phase 4
2
Top Sponsors
Centre Hospitalier Universitaire de Nīmes 1 trial
Second Affiliated Hospital, Zhejiang University, School of Medicine 1 trial
AHS Cancer Control Alberta 1 trial
Cajal Therapeutics Inc. 1 trial
Russian Federation of Anesthesiologists and Reanimatologists 1 trial

Recruiting Clinical Trials

NCT06060639
Recruiting
Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients
Enrollment
116 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06012760
Recruiting
The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
Enrollment
400 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
View Trial →
NCT05407987 Phase 3
Recruiting
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Enrollment
82 pts
Location
Canada
Sponsor
AHS Cancer Control Alberta
View Trial →
NCT07577817 EARLY_Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
Enrollment
72 pts
Location
Australia
Sponsor
Cajal Therapeutics Inc.
View Trial →
NCT03945968
Recruiting
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Enrollment
16,000 pts
Location
Russia
Sponsor
Russian Federation of Anesthes...
View Trial →
NCT07563582
Recruiting
Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia
Enrollment
60 pts
Location
Italy
Sponsor
Istituto Giannina Gaslini
View Trial →
NCT05384691 Phase 2
Recruiting
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
Enrollment
213 pts
Location
Germany
Sponsor
University of Leipzig
View Trial →
NCT06788691 Phase 2
Recruiting
Luspatercept for Clonal Cytopenias of Uncertain Significance
Enrollment
50 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT07699666
Recruiting
Delayed Versus Immediate Cord Clamping in Preterm Birth
Enrollment
200 pts
Location
Tunisia
Sponsor
Faculty of Medicine of Tunis
View Trial →
NCT06245746 Phase 1
Recruiting
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Enrollment
9 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
View Trial →
NCT07381426 Phase 3
Recruiting
Ferric Citrate in Iron Deficiency Anemia During Pregnancy
Enrollment
680 pts
Location
Bangladesh
Sponsor
Dhaka Medical College
View Trial →
NCT06499974
Recruiting
POASAC Study (Preoperative Anemia Severity and Classification Study)
Enrollment
1,000 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →
NCT06670963 Phase 4
Recruiting
Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial
Enrollment
200 pts
Location
Poland
Sponsor
Piotr Czempik
View Trial →
NCT05929729 Phase 4
Recruiting
Iron Deficiency Anemia (IDA) and the Brain
Enrollment
120 pts
Location
United States
Sponsor
Children's Hospital Los Angele...
View Trial →
NCT07315295
Recruiting
Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya
Enrollment
68 pts
Location
Kenya, Switzerland
Sponsor
ETH Zurich
View Trial →

Related Conditions

iron deficiencies (3) iron deficiency anemia (2) thrombocytopenia (2) neutropenia (2) age problem (1) ultrasonography (1) perioperative (1) transfusion (1) cardiac surgery (1) gynecologic cancer (1) iron deficiency (1) chronic kidney disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology